Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01215656
Other study ID # L. fermentum infections
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received October 5, 2010
Last updated October 6, 2010
Start date May 2008

Study information

Verified date October 2010
Source Puleva Biotech
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Interventional

Clinical Trial Summary

The objective of the study is to evaluate the effects of a follow on formula containing the human milk probiotic Lactobacillus fermentum on the incidence of infection in 6 months old infants.


Recruitment information / eligibility

Status Completed
Enrollment 188
Est. completion date
Est. primary completion date January 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 6 Months to 7 Months
Eligibility Inclusion Criteria:

- 6 months old children born at term

- written consent from parents

Exclusion Criteria:

- frequent gastrointestinal disorders (frequent diarrhoeas, constipation episodes, gastroesophageal reflux)

- gastrointestinal surgery

- cow's milk protein allergy

- metabolic diseases (diabetes or lactose intolerance)

- immune deficiency

- antibiotic treatment during the trial and/or recent (within the preceding 3 weeks)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention


Intervention

Dietary Supplement:
Lactobacillus fermentum

Follow on formula without probiotics


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Puleva Biotech

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of infectious diseases